CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text

Chimeric Antigen Receptor, Chronic Lymphoid Leukemia, Autoimmune Disease +13

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Michael Kalos, Bruce L. Levine, David L. Porter et al. · Science Translational Medicine · 2011 · 2.4K citations · Full text

NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy

Kim D. Pruitt, Tatiana Tatusova, Garth Brown et al. · Nucleic Acids Research · 2011 · 1.2K citations · Full text

CD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes

Robert H. Carter, Douglas T. Fearon · Science · 1992 · 673 citations

Autoimmune Disease, Antigen Receptor Stimulation, Hematology +15

Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice

Robert C. Rickert, Klaus Rajewsky · Nature · 1995 · 663 citations

Immunological Memory, B-l Cell Development, Developmental Biology +14